Clinical Trial Results
Showing:
All studies
[change]
Condition: Multiple Sclerosis
25 trials found
New Search
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
RECRUITING
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
RECRUITING
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
RECRUITING
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
RECRUITING
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
RECRUITING
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
RECRUITING
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
RECRUITING
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
RECRUITING
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
RECRUITING
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
RECRUITING
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
RECRUITING
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
RECRUITING
Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
RECRUITING
Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
RECRUITING
Molecular Imaging of NET Using [C-11]MRB-PET in MS
RECRUITING
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
RECRUITING
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
RECRUITING
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
RECRUITING
Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
RECRUITING
Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
RECRUITING
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
RECRUITING
Glucose Consumption in MS Using [F-18]FDG-PET
RECRUITING
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for MS
RECRUITING
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
RECRUITING